BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,710,445 | -24.7% | 694,821 | -0.1% | 0.27% | -15.1% |
| Q2 2023 | $22,204,793 | +4.3% | 695,421 | 0.0% | 0.32% | +2.6% |
| Q1 2023 | $21,293,791 | -21.9% | 695,421 | -0.2% | 0.31% | -14.6% |
| Q4 2022 | $27,248,758 | +0.0% | 696,721 | +21.9% | 0.36% | -7.4% |
| Q3 2022 | $27,237,000 | +22.9% | 571,721 | -0.2% | 0.39% | +24.9% |
| Q2 2022 | $22,166,000 | -33.6% | 572,621 | -1.8% | 0.31% | -19.3% |
| Q1 2022 | $33,396,000 | -31.6% | 582,821 | -4.9% | 0.39% | -22.9% |
| Q4 2021 | $48,836,000 | -8.4% | 612,821 | 0.0% | 0.50% | -7.0% |
| Q3 2021 | $53,321,000 | -32.4% | 612,821 | 0.0% | 0.54% | -29.7% |
| Q2 2021 | $78,876,000 | +73.9% | 612,821 | +8.1% | 0.77% | +60.4% |
| Q1 2021 | $45,368,000 | +40.0% | 566,821 | +42.8% | 0.48% | +29.4% |
| Q4 2020 | $32,396,000 | – | 396,821 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |